Bill Snyder

Cover of the VI4 AiR (Artist-in-Residence) 2022 annual report: B cells, antibodies and strands of free-flowing DNA represent B cell genome modification and the formation of unique antibodies. Illustration by Nadia Kafil, a UT-Austin biochemistry major who participated in the nationwide AiR program in the lab of Columbia University professor Uttiya Basu, PhD.
July 5, 2024

Vanderbilt Vaccine Center to begin artist-in-residence program this fall

The six-month-long “Visualizing Virology” residency is an extension of the VI4 Artist-in-Residence Program established in 2019 by the Vanderbilt Institute for Infection, Immunology and Inflammation (VI4), and supported by the Burroughs Wellcome Fund.

By Bill Snyder
Sarah Tishkoff, PhD
July 2, 2024

Sarah Tishkoff named to receive the 2024 Vanderbilt Prize in Biomedical Science

Sarah Tishkoff, PhD, and her collaborators have created one of the world’s largest databases of African diversity derived from genetic samples from more than 9,000 people representing more than 200 diverse ethnic groups.

By Bill Snyder
July 1, 2024

Vanderbilt mourns the loss of neonatal medicine pioneer Mildred Stahlman

Mildred T. Stahlman, MD, who pioneered the treatment of lung disease in premature infants and who was a tireless advocate of children of all ages, died June 29. She was 101.

By Bill Snyder
June 28, 2024

Antibody trial launched to address enterovirus threat

Enterovirus D68 has caused an increasing number of infections during the past decade and is associated with acute flaccid myelitis, a polio-like condition that mostly affects children and causes sudden weakness and paralysis.

By Bill Snyder
June 25, 2024

Gene variant may underlie diabetes disparities: study

The study was the largest ancestry-stratified, genetic estimation of the heritability of diabetic retinopathy conducted to date and included an unprecedented number of individuals of non-Hispanic African ancestry — more than 46,000.

By Bill Snyder
Registered respiratory therapist Natasha Vanderbilt, RRT, encourages 10-year-old Kate to exhale a complete breath during a lung function test in the Pediatric Pulmonary Medicine clinic. (photo by Susan Urmy)
June 14, 2024

Removing race improves accuracy of lung function testing in children

The study suggests the adjustment for race in spirometry resulted in an underreporting — and thus possibly undertreatment — of chronic lung diseases, including asthma and cystic fibrosis, in Black children.

By Bill Snyder
June 12, 2024

Scientists find antibodies that block parainfluenza virus infection

The antibodies may have clinical benefit as antiviral drugs to treat potentially life-threatening infections in elderly and immunosuppressed patients.
By Bill Snyder
June 7, 2024

Discovery raises hopes for new cancer therapy

The study connected the Hippo signaling pathway to phosphoinositides, a particular type of lipid, or fat molecule, which regulates cell functions that are critical in cancer, obesity and diabetes.
By Bill Snyder
June 4, 2024

Research raises hope for treating potentially lethal blood condition

Roughly 1 in 10 people over age 70 will develop CHIP, an explosive, clonal growth of abnormal blood cells that increases risk of blood cancers and death from cardiovascular, lung and liver disease.
By Bill Snyder
May 31, 2024

VUMC-led team reports potential new way to stimulate weight loss

Researchers at Vanderbilt University Medical Center and the VA Tennessee Valley Healthcare System have demonstrated in a small clinical study that “turning up the heat” on fat may help people lose weight and reduce their risk of obesity-related cardiovascular and metabolic disease.
By Bill Snyder
May 31, 2024

Antibodies may aid effort to fight influenza B: study

The findings reported in the journal Immunity support the development of a monoclonal antibody for prevention and treatment of influenza B — and will help guide efforts to develop a universal influenza vaccine.
By Bill Snyder
May 29, 2024

Kristin O’Grady receives $2.4 million for multiple sclerosis imaging studies

The awards will support O’Grady’s application of structural and functional magnetic resonance imaging to better understand symptoms and track MS progression in the lower spinal cord.
By Bill Snyder